Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 5, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 6, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001231589-26-000006
Filed / recorded
Mar 6, 2026, 2:37 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Paul A Mahon
Relationship
Officer
Officer title
EVP & GENERAL COUNSEL
Security
Stock Option
Table
Derivative (Table II)
Transaction date
Mar 5, 2026
Transaction code
M
Shares / units
8,300
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
33,500
Ownership form
Direct
Amendment
No
Footnotes from the filing
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.